SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-031576
Filing Date
2023-05-22
Accepted
2023-05-22 18:08:48
Documents
2
Period of Report
2023-05-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4168
2 POA DOCUMENT poa.txt EX-24 2109
  Complete submission text file 0001209191-23-031576.txt   7730
Mailing Address C/O ZYMOGENETICS, INC. 1201 EASTLAKE AVENUE SEATTLE WA 98102
Business Address
JOHNSON JAMES A (Reporting) CIK: 0001225501 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39503 | Film No.: 23945985

Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Issuer) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)